Baricitinib (brand name Olumiant®) is a tablet that belongs to a class of medicines called Janus Kinase (JAK) inhibitors.

Tofacitinib (brand name: Xeljanz) belongs to a class of medicines called non-biological disease modifying antirheumatic drugs.